Znn3bq.jpeg
²é¿´: 3502  |  »Ø¸´: 17
±¾Ìû²úÉú 1 ¸ö DRDEPI £¬µã»÷ÕâÀï½øÐв鿴

ronalbeck

Òø³æ (ÕýʽдÊÖ)


[½»Á÷] ÏÈÉùÒ©ÒµÒ»ÀàÐÂÒ©°¬À­ÄªµÂ»ñÅú ÒÑÓÐ15È˲ÎÓë

ÏÈÉùÒ©ÒµÒ»ÀàÐÂÒ©°¬À­ÄªµÂ»ñÅú  
2011-09-01  À´Ô´£ºÃ×ÄÚÍø   


      ºËÐÄÌáʾ£ºÏÈÉùÒ©Òµ¹«²¼Æä×ÔÖ÷Ñз¢µÄÖÎÁÆÀà·çʪÐԹؽÚÑ×ÐÂÒ©°¬À­ÄªµÂƬ (ÉÌÆ·Ãû£º°¬µÃÐÁ)Õýʽ»ñµÃ¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö£¨SFDA£©¹ú¼ÒÒ»ÀàÐÂÒ©Ö¤Êé¼°Ò©Æ·×¢²áÅúÎÄ¡£°¬µÃÐÁÊÇÈ«ÇòµÚÒ»¸öÉÏÊеݬÀ­ÄªµÂÖÆ¼Á¡£  

Ã×ÄÚÍø×¨¸å(Ñо¿Ô± Îâ¿¡½Ü)8ÔÂ24ÈÕ,ÏÈÉùÒ©ÒµÔÚÆä¹ÙÍø¹«²¼,Æä×ÔÖ÷Ñз¢µÄÐÂÒ©°¬À­ÄªµÂƬ (ÉÌÆ·Ãû:°¬µÃÐÁ)Õýʽ»ñµÃ¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö(SFDA)¹ú¼ÒÒ»ÀàÐÂÒ©Ö¤Êé¼°Ò©Æ·×¢²áÅúÎÄ¡£Åú×¼ÎĺÅΪ¹úÒ©×¼×ÖH20110084,¼ÁÐÍΪƬ¼Á,¹æ¸ñ25mg,ÏÈÉùҩҵͬʱ»ñµÃ°¬À­ÄªµÂµÄÔ­ÁÏÒ©ÅúÎÄ¡£

¾Ý½éÉÜ,°¬µÃÐÁÊÇÈ«ÇòµÚÒ»¸öÉÏÊеݬÀ­ÄªµÂÖÆ¼Á,Ò²ÊÇÒ»¸öȫнṹÀàÐ͵ÄDMARDS(Disease Modifying Anti-rheumatic Drugs,¼²²¡ÐÞÊο¹·çʪҩ)Ò©Îï,ÆäÖ÷ÒªÊÊӦ֢Ϊ»î¶¯ÐÔÀà·çʪÐԹؽÚÑ×,¿ÉÏÔÖø¸ÄÉÆÀà·çʪÐԹؽÚÑ×»¼Õߵļ²²¡Ö¢×´ºÍÑ×Ö¢Ö¸±ê,¼õÇỼÕßµÄÍ´¿à¡£

´ÓÃ×ÄÚÍø-»¯Ñ§Ò©ÁÙ´²ÓÃÒ©¾ºÕù¸ñ¾ÖÁ˽⵽,ÎÒ¹úÖÎÁÆÀà·çʪÐԹؽÚÑ×Ò©ÎïÖ÷ÒªÓа±»ùÆÏÌÑÌÇ¡¢Â¹¹Ï¶àëÄ¡¢·ú±ÈÂå·Ò¡¢ÈûÀ´Îô²¼µÈ,Êг¡¸ñ¾ÖÈçÏÂͼ¡£




½ñÄêÒÔÀ´,Óжà¸öÒ»ÀàÐÂÒ©»ñÅú,Ïà¹ØÇé¿öÈçϱí:

Ò©Ãû
¹«Ë¾
ÏêÇé

ÑÎËá°£¿ËÌæÄáÆ¬
±´´ïÒ©Òµ
Ò»ÀàÐÂÒ©ÑÎËá°£¿ËÌæÄáÉÏÊÐ

°¬ÈðÎô²¼Æ¬
ºãÈðÒ½Ò©
Ò»ÀàÐÂÒ©°¬ÈðÎô²¼»ñÅú

×¢ÉäÓÃÖØ×éÈËÄò¼¤Ã¸Ô­
ÉϺ£ÌìÊ¿Á¦Ò©Òµ
¶þ¼¾¶È¶à¸öÒ»ÀàÐÂÒ©»ñÉú²úÅúÎÄ

×¢ÉäÓÃÍ·æßÇúËÉÄÆÊæ°ÍÌ¹ÄÆ
Ïæ±±Íþ¶ûÂü
  

°¬À­ÄªµÂƬ
ÏÈÉùÒ©Òµ
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
2Â¥2011-09-01 14:22:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hardee

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

´Ë²ÝÓÐÖ÷~

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
zhychen2008(½ð±Ò+1, DRDEPI+1): ¶àлÌṩÐÅÏ¢ 2011-09-03 16:03:22


Meantime, Eisai and Toyama Chemical Co have submitted a marketing authorisation application  for T-614 (iguratimod), an anti-rheumatic agent being jointly developed in Japan by the two companies.

T-614 is a novel disease modifying anti-rheumatic drug originally discovered by Toyama and an MAA was previously submitted in 2003. However, the application was temporarily withdrawn in 2009 in order to conduct an additional clinical study which subsequently confirmed with statistical significance the efficacy of the agent as an add-on therapy for use with the standard of care, methotrexate.

http://www.pharmatimes.com/Artic ... epsy_portfolio.aspx

Ö»ÄÜ˵ÊÇÏÈÉùµÄÔËÆøºÃÁË¡£¡£¡£

[ Last edited by hardee on 2011-9-1 at 15:17 ]
°²µÃ´ÙÏ¥£¬¿É¹²Æ½Éú¡£
3Â¥2011-09-01 14:58:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhenyu19

ľ³æ (СÓÐÃûÆø)

à½à½

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
¹úÍâûÅú£¬¹úÄÚÏÈÅúÁË£¿Õâ¾ÍÊÇ´«ËµÖеÄ1Àà°¡¡£
4Â¥2011-09-01 16:16:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ò©µÀÈË

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

¾»ÓÉ»àÉú£¬Ã÷´Ó霳ö

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
zhychen2008(½ð±Ò+1): ¶àл²ÎÓë 2011-09-03 16:03:38
DMARDSÔçÒÑÊôÓÚ¶þÏßÓÃÒ©,ÓкÎÒâÒå
À´Ê±ºúͿȥʱÃÔ£¬¿ÕÔÚÈ˼ä×ßÕâ»Ø¡£Î´ÔøÉúÎÒË­ÊÇÎÒ£¬ÉúÎÒÖ®ºóÎÒÊÇË­£¿³¤´ó³ÉÈË·½ÖªÎÒ£¬ºÏÑÛëüëÊÓÖÊÇË­£¿²»Èç²»À´Ò²²»È¥£¬ÒàÎÞ·³ÄÕÒàÎÞ±¯¡£
5Â¥2011-09-02 09:48:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dudu235

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÏÈÉùºãÈð±´´ïÐÂÒ©Ñз¢ÒѾ­ÁìÏÈÁË Á˲»Æð Íþ¶ûÂüÔõôû̫Ìý˵¹ý£¿
ʱ¼äºã¾ÃÔ¶ËêÔ²»ÈÄÈË
6Â¥2011-09-02 10:28:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lpw106

Òø³æ (СÓÐÃûÆø)

»¹¿ÉÒÔ
7Â¥2011-09-02 11:03:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ö§³Ö°É£¡
8Â¥2011-09-02 11:04:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1994yw

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
zhychen2008(½ð±Ò+1): ¸Ðл»ØÌû½»Á÷ 2011-09-03 16:04:12
¶ÔÓÚ°¬À­ÄªµÂÕâ¸öËùνµÄÒ»ÀàÐÂÒ©£¬Ô¤¼ÆÎ´À´»¹ÓÐÁ½¸öÅúÎÄÏÂÀ´£¬¾Í¸ú¶÷Ìæ¿¨Î¤Ò»Ñù£¬12¸öÔÂÄÚÁ¬ÐøÅú³öÀ´Èý¸öÒ»ÀàÐÂÒ©¡£
ÕæÓÐÒâ˼£¡
9Â¥2011-09-02 11:06:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

iijs

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
»áÅúµØ£¬ÖØ´óרÏî´ÕÊýÒ²ÒªÅú¡£
10Â¥2011-09-02 11:50:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ronalbeck µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0703»¯Ñ§ +31 ÄÝÄÝninicgb 2026-04-04 35/1750 2026-04-09 21:06 by zhouxiaoyu
[¿¼ÑÐ] Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á +10 ÔÙæҲҪ³Ô·¹°¡ 2026-04-08 11/550 2026-04-09 19:51 by gong120082
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄÏ´óѧÉúÎïѧѧ˶344 ÇóÉúÎïѧÏà¹Øµ÷¼Á/ÉúÎïÓëÒ½Ò© +7 ³¬È˲»»á·É@ 2026-04-08 7/350 2026-04-09 09:35 by gong120082
[¿¼ÑÐ] 286Çóµ÷¼Á +19 Faune 2026-04-08 20/1000 2026-04-09 08:36 by ŶŶ123
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤085601²ÄÁϹ¤³Ì303·ÖÇóµ÷¼Á +15 a1708 2026-04-06 15/750 2026-04-08 16:23 by luoyongfeng
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶ 285Çóµ÷¼Á +26 Wisjxn 2026-04-07 26/1300 2026-04-08 14:42 by screening
[¿¼ÑÐ] 277¡¢Ñ§Ë¶£¬Çóµ÷¼Á ÊýÒ»104£¬ +11 Æ¿×ÓPZ 2026-04-07 12/600 2026-04-07 23:30 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] 22408 318·ÖÇóµ÷¼Á +4 ÇڷܵÄСÁý°ü 2026-04-06 6/300 2026-04-07 15:05 by Ö½º×555
[¿¼ÑÐ] 307Çóµ÷¼Á +3 Youth@@ 2026-04-07 3/150 2026-04-07 09:25 by СºÚ²»ÅÂÄÑ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +10 cs0106 2026-04-05 12/600 2026-04-06 19:41 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©Çóµ÷¼Á +7 heguanhua 2026-04-05 8/400 2026-04-06 18:41 by macy2011
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õij211 0703»¯Ñ§×Ü·Ö339Çóµ÷¼Á +7 Íí·ç²»Íí 2026-04-04 7/350 2026-04-06 14:06 by houyaoxu
[¿¼ÑÐ] 0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319 +14 lv945 2026-04-04 14/700 2026-04-06 10:20 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 302·Ö 085601Çóµ÷¼ÁÍÆ¼ö +11 zyxÉϰ¶£¡ 2026-04-05 11/550 2026-04-05 22:13 by dongzh2009
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©µ÷¼Á +4 Ê®Æßsa 2026-04-05 4/200 2026-04-05 20:05 by lys0704
[¿¼ÑÐ] ¿¼Ñе÷¼ÁÉúѰÕÒµ¼Ê¦ +3 ¹ËÕ°¿¼Ñа¡ 2026-04-05 3/150 2026-04-05 18:18 by à£à£à£0119
[¿¼ÑÐ] µ÷¼Á +8 ÐܶþÏëÉϰ¶ 2026-04-04 8/400 2026-04-05 05:27 by houyaoxu
[¿¼ÑÐ] Çóµ÷¼Á +8 akdhjs 2026-04-03 8/400 2026-04-03 18:17 by ´÷άING
[¿¼ÑÐ] 366Çóµ÷¼Á +7 sbdnd 2026-04-03 7/350 2026-04-03 12:40 by cymywx
[¿¼ÑÐ] 320Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 3/150 2026-04-03 11:40 by ÍÁľ˶ʿÕÐÉú
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û